The Fraud Scandal Of Glaxosmithkline

1927 Words Nov 16th, 2015 8 Pages
GSK Analysis This paper covers the information given from the bribery scandal that GSK paid off the Chinese government and doctors in the country. This analysis will take a look at what happened, what went wrong and the conclusion for the company looking in the future to do business in China. The company’s response is a key issue in how they came back from such a detrimental hit in a growing market. There are a number of factors that will be interpreted and discussed for the future dealings in China and how other businesses must overcome these laws to make sure they are in compliance with international laws.
Questions Arise The first question to arise would be what kind of laws does China already have in place and how long have they
…show more content…
This law makes it a crime of bribery with a government official who is conducting an investigation. This was seen done by GlaxoSmithKline in combination with bribing doctors to prescribe their medications. Whether an illegal paying off has happened is to be determined chiefly on the collective bribery totals and the purpose of the presented money or property (Rogers, 2014). These laws coincide with the third party code of conduct that GlaxoSmithKline has in place for dealing with bribes. GlaxoSmithKline has a zero tolerance policy on this kind of dealings. Furthermore, they say anyone who is representing the company either employed or acting on the behalf of the company falls under this policy (GlaxoSmithKline, 2015). The main factor contributing to shady business practices would be the outside influence of the Chinese and their culture. This would include not only officials who are with the Chinese government, but the doctors who are looking for the bribes as well. It was seen more as a common practice in the country as these laws are not very old. The importance of the outside factors is much more prevalent than those of internal. The external factor of bribery being the business norm outweighs the internal auditing that obviously did not take place as they said was happening in all international deals. There are wrongs on

More about The Fraud Scandal Of Glaxosmithkline

Open Document